Literature DB >> 4368637

Effect of DB-c-AMP on mechanical characteristics of ventricular and atrial preparations of several mammalian species.

T Meinertz, H Nawrath, H Scholz, K Winter.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4368637     DOI： 10.1007/bf00499029

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN： 0028-1298            Impact factor:   3.000


× No keyword cloud information.
  18 in total

1.  Inotropic and chronotropic effects of dibutyryl cyclic AMP.

Authors:  G I Drummond; S J Hemmings
Journal:  Adv Cyclic Nucleotide Res       Date:  1972

2.  The role of cyclic AMP in the inotropic response to isoprenaline and glucagon.

Authors:  I Oye; A Langslet
Journal:  Adv Cyclic Nucleotide Res       Date:  1972

Review 3.  Structure-activity relationships for inhibitors of phosphodiesterase from erythrocytes and other tissues.

Authors:  H Sheppard; G Wiggan; W H Tsien
Journal:  Adv Cyclic Nucleotide Res       Date:  1972

4.  Inhibition of cyclic-3',5'-nucleotide-phosphodiesterase as a possible mode of action of papaverine and similarly acting drugs.

Authors:  W R Kukovetz; G Pöch
Journal:  Naunyn Schmiedebergs Arch Pharmakol       Date:  1970

5.  Inotropic and metabolic effects of dibutyryl cyclic adenosine 3', 5'-monophosphate in the perfused rat heart.

Authors:  K Ahrén; A Hjalmarson; O Isaksson
Journal:  Acta Physiol Scand       Date:  1971-05

6.  [Influence of cardio- and vasoactive substances on phosphodiesterase activity].

Authors:  G Pöch; H Juan; W R Kukovetz
Journal:  Naunyn Schmiedebergs Arch Pharmakol       Date:  1969

7.  Cardiostimulatory effects of cyclic 3',5'-adenosine monophosphate and its acylated derivatives.

Authors:  W R Kukovetz; G Pöch
Journal:  Naunyn Schmiedebergs Arch Pharmakol       Date:  1970

8.  Positive inotropic effects of dibutyryl cyclic adenosine 3',5'-monophosphate.

Authors:  C L Skelton; G S Levey; S E Epstein
Journal:  Circ Res       Date:  1970-01       Impact factor: 17.367

9.  [Influence of the frequency of contraction on the action potential of the guinea pig papillary muscle].

Authors:  M Reiter; F J Stickel
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1968

10.  The effect of epinephrine on adenosine 3', 5'-phosphate levels in the isolated perfused rat heart.

Authors:  G A Robison; R W Butcher; I Oye; H E Morgan; E W Sutherland
Journal:  Mol Pharmacol       Date:  1965-09       Impact factor: 4.436
View more
  6 in total

1.  Effects of papaverine and its interaction with isoprenaline and carbachol on the contractile force and cyclic nucleotide levels of the canine ventricular myocardium.

Authors:  M Endoh; M Honma
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-04       Impact factor: 3.000

2.  Electrical and mechanical activity of mammalian heart fibres treated with papaverine. Interaction with isoprenaline and dibutyryl cyclic AMP.

Authors:  H Nawrath; T Meinertz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-10       Impact factor: 3.000

3.  Effects of several phosphodiesterase-inhibitors on guinea-pig myocardium.

Authors:  M Korth
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-03       Impact factor: 3.000

4.  Opposite effects of beta-adrenoceptor stimulation and 8-bromo-cyclic AMP on potassium efflux in mammalian heart muscle.

Authors:  H Nawrath; I Blei; R Gegner
Journal:  Experientia       Date:  1980-01-15

5.  Multiple effects of putative alpha-adrenoceptor agonists on the electrical and mechanical activity of guinea-pig papillary muscle.

Authors:  J Sanchez-Chapula
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-04       Impact factor: 3.000

6.  Possible role of cyclic AMP in the relaxation process of mammalian heart: effects of dibutyryl cyclic AMP and theophylline on potassium contractures in cat papillary muscles.

Authors:  T Meinertz; H Nawrath; H Scholz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976-05       Impact factor: 3.000
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.